title: Identifying rare events in rare diseases.
abstract: Utilizing genomic signatures from diagnostic tumor samples to forecast clinical behavior and response to therapy has long been a goal, and we are now poised to further refine how we can identify the relatively rare patients with aggressive neuroblastoma masquerading as patients with a more benign form of the disease. Clin Cancer Res; 21(8); 1782-5. ©2014 AACR. See related article by Oberthuer et al., p. 1904.
authors.affiliation: Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Edward F
authors.initials: EF
authors.lastname: Attiyeh
authors.affiliation: Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Maris@email.chop.edu.
authors.forename: John M
authors.initials: JM
authors.lastname: Maris
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D009447:Neuroblastoma / Q000235:genetics* / Q000401:mortality*
chemical_list: D014408:Biomarkers, Tumor